Effects of topiramate on smoking in patients with schizoaffective disorder, bipolar type

Journal of Clinical Psychopharmacology

Volumn 28, Issue 2, 2008, Pages 247-248

  Weinberger, Andrea H ^a   George, Tony P ^b   Perkins, Kenneth A ^c   Chengappa, K N Roy ^c,d  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF PITTSBURGH   (United States)

^d Mayview State Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; TOPIRAMATE;

BIPOLAR DISORDER; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; HUMAN; LETTER; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCHIZOAFFECTIVE PSYCHOSIS; SMOKING HABIT;

ADOLESCENT; ADULT; ANTICONVULSANTS; BIPOLAR DISORDER; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FRUCTOSE; HUMANS; MALE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RETROSPECTIVE STUDIES; SMOKING; TREATMENT OUTCOME;

EID: 40949111085     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/JCP.0b013e31816740cf     Document Type: Letter

References (11)

1. Johnson BA. Recent advances in the development of treatments for alcohol and cocaine dependence: focus on topiramate and other modulators of GABA or glutamate function. CNS Drugs. 2005;19:873-896.
2. Johnson BA, Ait-Daoud N, Bowden CL, et al. Oral topiramate for treatment of alcohol dependence: a randomized controlled trial. Lancet. 2003;361:1677-1685.
3. Johnson BA, Ait-Daoud N, Akhtar FZ, et al. Use of oral topiramate to promote smoking abstinence among alcohol-dependent smokers. Arch Intern Med. 2005;165:1600-1605.
4. Khazaal Y, Cornuz J, Bilancioni R, et al. Topiramate for smoking cessation. Psychiatr Clin Neurosci. 2006;60:384-388.
5. Anthenelli RM, Blom TJ, McElroy SL, et al. A double-blind, placebo-controlled trial of topiramate as an aid to smoking cessation. Poster presented at: 12th Annual Meeting of the Society for Research on Nicotine and Tobacco; February 15-18, 2006; Orlando, FL.
6. Reid MS, Palamer J, Raghavan S, et al. Effects of topiramate on cue-induced cigarette craving and the response to a smoked cigarettes in briefly abstinent smokers. Psychopharmacology (Berl). 2007;192:147-158.
7. Sofuoglu M, Poling J, Mouratidis M, et al. Effects of topiramate in combination with intravenous nicotine in overnight abstinent smokers. Psychopharmacology (Berl). 2006;184:645-651.
8. Kalman D, Morrisette SB, George TP. Comorbidity of smoking with psychiatric and substance use disorders. Am J Addict. 2005;14:106-123.
9. Chengappa KNR, Kupfer DJ, Parepally H, et al. A placebo-controlled, random-assignment, parallel-group pilot study of adjunctive topiramate for patients with schizoaffective disorder, bipolar type. Bipolar Disord. 2007;9:609-617.
10. de Leon J, Diaz FJ. A meta-analysis of world-wide studies demonstrates an association between schizophrenia and tobacco smoking behaviors. Schizophrenia Res. 2005;76:135-157.
11. Perkins KA, Stitzer M, Lerman C. Medication screening for smoking cessation: a proposal for new methodologies. Psychopharmacology. 2006;184:628-636.